HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents.

Abstract
The μ1 opioid receptor (OPRM1) genetic variant A118G results in decreased μ-receptor binding potential in the brain and increases morphine requirement. We hypothesized that OPRM1 A118G polymorphism will affect morphine-induced respiratory depression (MIRD) risk in children receiving morphine. A prospective genotype-blinded study was conducted in 88 healthy adolescents (11-18 years; 67% female, 85% Caucasian) who underwent spine fusion for scoliosis. They were followed for 48 h postoperatively for MIRD, pain scores, morphine consumption and use of analgesic adjuvants. Patients were genotyped for OPRM1 A118G variant-76% were wild type (AA) and 24% heterozygous/homozygous for variant (AG/GG). Multivariable logistic regression showed that the risk of MIRD in patients with AA genotype was significantly higher (odds ratio 5.6, 95% CI: 1.4-37.2, P=0.030). Presence of G allele was associated with higher pain scores (effect size 0.73, P=0.045). This novel association is an important step toward predicting MIRD susceptibility and personalizing morphine use.
AuthorsV Chidambaran, J Mavi, H Esslinger, V Pilipenko, L J Martin, K Zhang, S Sadhasivam
JournalThe pharmacogenomics journal (Pharmacogenomics J) Vol. 15 Issue 3 Pg. 255-62 (Jun 2015) ISSN: 1473-1150 [Electronic] United States
PMID25266679 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Opioid
  • OPRM1 protein, human
  • Receptors, Opioid, mu
  • Morphine
Topics
  • Adolescent
  • Alleles
  • Analgesics, Opioid (administration & dosage, adverse effects)
  • Child
  • Female
  • Genotype
  • Homozygote
  • Humans
  • Male
  • Morphine (administration & dosage, adverse effects)
  • Polymorphism, Single Nucleotide (genetics)
  • Prospective Studies
  • Receptors, Opioid, mu (genetics, metabolism)
  • Respiratory Insufficiency (chemically induced, genetics, metabolism)
  • Risk
  • Scoliosis (surgery)
  • Spine (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: